221 related articles for article (PubMed ID: 35726023)
1. The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.
Giannuzzi D; Marconato L; Fanelli A; Licenziato L; De Maria R; Rinaldi A; Rotta L; Rouquet N; Birolo G; Fariselli P; Mensah AA; Bertoni F; Aresu L
Lab Anim (NY); 2022 Jul; 51(7):191-202. PubMed ID: 35726023
[TBL] [Abstract][Full Text] [Related]
2. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Reddy A; Zhang J; Davis NS; Moffitt AB; Love CL; Waldrop A; Leppa S; Pasanen A; Meriranta L; Karjalainen-Lindsberg ML; Nørgaard P; Pedersen M; Gang AO; Høgdall E; Heavican TB; Lone W; Iqbal J; Qin Q; Li G; Kim SY; Healy J; Richards KL; Fedoriw Y; Bernal-Mizrachi L; Koff JL; Staton AD; Flowers CR; Paltiel O; Goldschmidt N; Calaminici M; Clear A; Gribben J; Nguyen E; Czader MB; Ondrejka SL; Collie A; Hsi ED; Tse E; Au-Yeung RKH; Kwong YL; Srivastava G; Choi WWL; Evens AM; Pilichowska M; Sengar M; Reddy N; Li S; Chadburn A; Gordon LI; Jaffe ES; Levy S; Rempel R; Tzeng T; Happ LE; Dave T; Rajagopalan D; Datta J; Dunson DB; Dave SS
Cell; 2017 Oct; 171(2):481-494.e15. PubMed ID: 28985567
[TBL] [Abstract][Full Text] [Related]
3. Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.
El Hussein S; Shaw KRM; Vega F
Mod Pathol; 2020 Dec; 33(12):2422-2436. PubMed ID: 32620919
[TBL] [Abstract][Full Text] [Related]
4. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
Karube K; Enjuanes A; Dlouhy I; Jares P; Martin-Garcia D; Nadeu F; Ordóñez GR; Rovira J; Clot G; Royo C; Navarro A; Gonzalez-Farre B; Vaghefi A; Castellano G; Rubio-Perez C; Tamborero D; Briones J; Salar A; Sancho JM; Mercadal S; Gonzalez-Barca E; Escoda L; Miyoshi H; Ohshima K; Miyawaki K; Kato K; Akashi K; Mozos A; Colomo L; Alcoceba M; Valera A; Carrió A; Costa D; Lopez-Bigas N; Schmitz R; Staudt LM; Salaverria I; López-Guillermo A; Campo E
Leukemia; 2018 Mar; 32(3):675-684. PubMed ID: 28804123
[TBL] [Abstract][Full Text] [Related]
5. Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma.
Mareschal S; Dubois S; Viailly PJ; Bertrand P; Bohers E; Maingonnat C; Jaïs JP; Tesson B; Ruminy P; Peyrouze P; Copie-Bergman C; Fest T; Jo Molina T; Haioun C; Salles G; Tilly H; Lecroq T; Leroy K; Jardin F
Genes Chromosomes Cancer; 2016 Mar; 55(3):251-67. PubMed ID: 26608593
[TBL] [Abstract][Full Text] [Related]
6. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
Rossi D; Gaidano G
Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
[TBL] [Abstract][Full Text] [Related]
7. Genomic profiling using array comparative genomic hybridization define distinct subtypes of diffuse large B-cell lymphoma: a review of the literature.
Tirado CA; Chen W; García R; Kohlman KA; Rao N
J Hematol Oncol; 2012 Sep; 5():54. PubMed ID: 22967872
[TBL] [Abstract][Full Text] [Related]
8. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.
Steen CB; Luca BA; Esfahani MS; Azizi A; Sworder BJ; Nabet BY; Kurtz DM; Liu CL; Khameneh F; Advani RH; Natkunam Y; Myklebust JH; Diehn M; Gentles AJ; Newman AM; Alizadeh AA
Cancer Cell; 2021 Oct; 39(10):1422-1437.e10. PubMed ID: 34597589
[TBL] [Abstract][Full Text] [Related]
9. Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.
Bohers E; Mareschal S; Bertrand P; Viailly PJ; Dubois S; Maingonnat C; Ruminy P; Tilly H; Jardin F
Leuk Lymphoma; 2015 May; 56(5):1213-22. PubMed ID: 25130477
[TBL] [Abstract][Full Text] [Related]
10.
Fanelli A; Marconato L; Licenziato L; Minoli L; Rouquet N; Aresu L
Front Vet Sci; 2022; 9():968807. PubMed ID: 36016811
[TBL] [Abstract][Full Text] [Related]
11. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy.
Curran KM; Schaffer PA; Frank CB; Lana SE; Hamil LE; Burton JH; Labadie J; Ehrhart EJ; Avery PR
Vet Comp Oncol; 2017 Dec; 15(4):1269-1279. PubMed ID: 27514648
[TBL] [Abstract][Full Text] [Related]
12. Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles.
Dubois S; Tesson B; Mareschal S; Viailly PJ; Bohers E; Ruminy P; Etancelin P; Peyrouze P; Copie-Bergman C; Fabiani B; Petrella T; Jais JP; Haioun C; Salles G; Molina TJ; Leroy K; Tilly H; Jardin F;
EBioMedicine; 2019 Oct; 48():58-69. PubMed ID: 31648986
[TBL] [Abstract][Full Text] [Related]
13. Genetic heterogeneity of diffuse large B-cell lymphoma.
Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Mieczkowski PA; Dunphy C; Choi W; Au WY; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers C; Naresh K; Evens A; Gordon LI; Czader M; Gill JI; Hsi ED; Liu Q; Fan A; Walsh K; Jima D; Smith LL; Johnson AJ; Byrd JC; Luftig MA; Ni T; Zhu J; Chadburn A; Levy S; Dunson D; Dave SS
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1398-403. PubMed ID: 23292937
[TBL] [Abstract][Full Text] [Related]
14. STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.
Assumpção ALFV; Jark PC; Hong CC; Lu Z; Ruetten HM; Heaton CM; Pinkerton ME; Pan X
J Vet Intern Med; 2018 Jan; 32(1):361-369. PubMed ID: 29119628
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the disease.
Chapuy B; Cheng H; Watahiki A; Ducar MD; Tan Y; Chen L; Roemer MG; Ouyang J; Christie AL; Zhang L; Gusenleitner D; Abo RP; Farinha P; von Bonin F; Thorner AR; Sun HH; Gascoyne RD; Pinkus GS; van Hummelen P; Wulf GG; Aster JC; Weinstock DM; Monti S; Rodig SJ; Wang Y; Shipp MA
Blood; 2016 May; 127(18):2203-13. PubMed ID: 26773040
[TBL] [Abstract][Full Text] [Related]
16. Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.
Jardin F
Discov Med; 2014; 18(97):51-65. PubMed ID: 25091488
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood lymphocyte/monocyte ratio as a useful prognostic factor in dogs with diffuse large B-cell lymphoma receiving chemoimmunotherapy.
Marconato L; Martini V; Stefanello D; Moretti P; Ferrari R; Comazzi S; Laganga P; Riondato F; Aresu L
Vet J; 2015 Nov; 206(2):226-30. PubMed ID: 26403958
[TBL] [Abstract][Full Text] [Related]
18. Biological and Clinical Relevance of Associated Genomic Alterations in MYD88 L265P and non-L265P-Mutated Diffuse Large B-Cell Lymphoma: Analysis of 361 Cases.
Dubois S; Viailly PJ; Bohers E; Bertrand P; Ruminy P; Marchand V; Maingonnat C; Mareschal S; Picquenot JM; Penther D; Jais JP; Tesson B; Peyrouze P; Figeac M; Desmots F; Fest T; Haioun C; Lamy T; Copie-Bergman C; Fabiani B; Delarue R; Peyrade F; André M; Ketterer N; Leroy K; Salles G; Molina TJ; Tilly H; Jardin F
Clin Cancer Res; 2017 May; 23(9):2232-2244. PubMed ID: 27923841
[No Abstract] [Full Text] [Related]
19. NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
Gaurnier-Hausser A; Patel R; Baldwin AS; May MJ; Mason NJ
Clin Cancer Res; 2011 Jul; 17(14):4661-71. PubMed ID: 21610150
[TBL] [Abstract][Full Text] [Related]
20. [Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma].
Shimada K
Rinsho Ketsueki; 2017; 58(10):2033-2042. PubMed ID: 28978846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
